Roughly the same proportion of patients received iron during the course of the study, although the ferritin concentration (a marker of iron stores and of inflammation) was higher on average in the placebo group
The FDA emphasizes that many compounded semaglutide products may use salt forms (such as semaglutide sodium or acetate), which differ from the active ingredients in approved formulations and lack evidence of safety or efficacy
A loss of around 15 percent of body weight is the norm on Wegovy
Hair loss Hair loss on GLP-1 is a documented side effect related to rapid weight loss and potential nutrient deficiencies, not the medication itself directly
Another two trials from the SURMOUNT programme have recently been published [48, 49]
Lilly's Double-Beat Widens the GLP-1 GapAnd a New Pill Could Make It Permanent The $63-billion GLP-1 agonist industry is forecast to triple in the coming decade, so it's no surprise that pharmaceuticals companies of all sizes are scrambling to get in on the action